Eris Lifesciences Limited (ERIS) Share Analysis
NSE · Healthcare · Pharmaceuticals
Eris Lifesciences Limited (NSE: ERIS) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 21 Sep 2026, the share price was ₹1,321.00, market capitalisation ₹18,311 Cr, P/E 27.9, ROE 18.7%.
Get the AI verdict on ERIS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
ERIS price and valuation
- Share price
- ₹1,321.00
- Market cap
- ₹18,311 Cr
- P/E ratio
- 27.9
- P/B ratio
- 4.68
- EPS
- ₹46.75
- Book value per share
- ₹282.00
- Dividend yield
- 0.55%
ERIS profitability and growth
- ROE
- 18.7%
- ROCE
- 14.1%
- Debt to equity
- 0.61
- Revenue growth (3 yr)
- 23%
- Revenue growth (5 yr)
- 21%
- Profit growth (3 yr)
- 19%
- Profit growth (5 yr)
- 12%
ERIS 52-week range
- 52-week high
- ₹1,740.00
- 52-week low
- ₹1,200.00
- Face value
- ₹1.00
ERIS shareholding pattern
- Promoters
- 54.14%
- FIIs
- 5.76%
- DIIs
- 20.71%
- Public
- 19.39%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.